there were only about 4.5 million shares short as of August 31 settlement. Those have had to have been covered today. There is no reason to own this stock anymore. With the botched trial the FDA will probably never approve this thing. The stock is done. You are crazy to buy more. The institutions that specialize in the bio-tech sector never touched this one. Must have been a good reason, don't you agree? Get out why you can.